Sudarshan Chemical Industries Ltd Q2 FY2026 Concall Summary & Transcript Notes

Source transcript PDF: https://www.stockscans.in/document/oc5rnirc49vw2ga1hm7a12w6.pdf

# 1. Financial Performance

## A. Key Figures
   *   **H1 EBITDA (Legacy Sudarshan):** **₹178 Cr**
   *   **H1 Turnover (Acquired Group):** **₹3,565 Cr** · **EBITDA:** **₹103 Cr** (3% margin)
   *   **Inventory Reduction:** **₹100 Cr** reduction in stand-alone business
   * Net Working Capital: 26.2% of sales (target: 24% by FY '27)

## B. Revenue Trends
   *   **Disappointing Q2 Performance:** Sales flat YoY despite strong fundamentals, impacted by temporary demand dip and high customer inventory levels.
   *   **Sequential Improvement:** Revenue showed **13% QoQ growth**, indicating recovery momentum into H2.
   *   **Q3 Visibility Challenges:** Unusual quarter-end dynamics and geographic inactivity distort Q2–Q3 comparability, creating unprecedented mix effects.

## C. EBITDA Margins
   *   **Margin Pressure from Low Utilization:** EBITDA declined more than sales due to weak operating leverage from production cuts, not input costs.
   *   **Path to Margin Recovery:** Outlook for **14–15% EBITDA margins** supported by expected demand rebound and structural cost controls.
   *   **Acquired Business Integration:** New group contributing at scale but currently dilutive with **3% EBITDA margin**, highlighting integration and turnaround opportunity.

## D. Balance Sheet
   *   **Debtor Realization Complete:** Full collection from insolvent group’s debtors achieved in first two post-acquisition quarters; no further inflows expected.

## E. Cash Flow
   *   **Working Capital Tailwinds Ahead:** Inventory normalization and low working capital intensity (2% of sales) position company for cash release and reinvestment.

---

# 2. Volume & Demand Trends
  
## A. Key Figures
   *No significant quantitative financial metrics available for extraction.*

## B. Customer Destocking
   *   **Near-Term Rebound Expected:** Customer destocking pressures anticipated to ease imminently, paving way for a strong sales recovery and improved value realization.

## C. Regional Demand
   *   **Weak Global Pigment Demand:** Softness in Europe, U.S., and LatAm driven by high interest rates dampening consumer spending, particularly in coatings and plastics end-markets.  
   *   **Australia Positioning Clarified:** Existing minor presence with recent adjustments reflecting a small-scale go-to-market refinement, not a strategic expansion.

## D. Seasonal Impact
   *   **Pronounced Seasonality:** Q4 historically strongest due to legacy business patterns; Q3 typically weakest owing to holiday-related shutdowns in Western markets.

---

# 3. Product & Segment Performance

## A. Key Figures
   *   **Legacy Sudarshan Pigment Revenue:** **₹1,330 Cr** H1 FY26 (-6%)
   *   **Acquired Group (Heubach) Pigment Run Rate:** **₹590 Cr** H1 FY26
   *   **Q2 Pigment Business Growth:** **+12% QoQ**
   *   **Legacy Pigment Business Growth:** **12%–13%**

## B. Pigment Business
   *   **Mixed Segment Performance:** Legacy pigment business declined slightly despite **strong plastics demand in India**, offset by softness in coatings and weak performance in Europe and North LatAm.
   *   **Acquisition Integration Challenges:** Heubach operations faced headwinds from **excess customer inventory and soft demand**, weighing on volume and margins, though value capture initiatives restored profitability.
   *   **Positive Q2 Surprise:** Pigment segment delivered **12% quarter-on-quarter growth**, reversing Q1 softness, signaling stronger-than-expected demand or execution improvement.
   *   **Strategic Optimization Underway:** Technical teams are advancing **recipe harmonization, in-sourcing, and footprint rationalization**, with progress in standardizing core formulations post-acquisition.
   *   **Consolidated Market Position:** Post-Heubach/Clariant integration, the combined entity forms one of **only two global pigment powerhouses**, alongside DIC Group, with leadership in **coatings, digital inks, and plastics**.

## C. Specialty Applications
   *   **Portfolio Expansion & Innovation Revival:** Acquisition unlocks access to high-value applications in **electronics (iPhone, Samsung), agrochemicals, and stationery**, while restructured R&D teams are reaccelerating innovation after a two-year hiatus.
   *   **Strategic Client Engagement:** Active collaboration with **Apple and Samsung** is generating increased product development inquiries, signaling potential future revenue pipelines in premium specialty segments.

---

# 4. Cost & Capacity Optimization

## A. Key Figures
   *   **Capex:** **₹700 Cr** executed over past 3–4 years  
   *   **Manufacturing Sites:** **17** outside India, **5** in India  
   *   **Target EBITDA:** **$90–100 Mn** by FY28–FY29

## B. Fixed Cost Reduction
   *   **Structural Cost Pressures:** High fixed costs in manufacturing remain inflexible to volume fluctuations, posing ongoing challenges.  
   *   **Active Cost Rationalization:** IT contracts renegotiated and high-cost applications retired; SG&A streamlining underway with duplicate roles eliminated.  
   *   **Long-Term Levers:** Global Capability Center (GCC) and ONE SAP implementation expected to deliver sustained cost leverage despite regulatory delays.  
   *   **Working Capital Focus:** Process alignment and integrated planning systems to drive future working capital reduction.  
   *   **Heubach-Level Review:** Systematic effort underway to reduce fixed costs and enhance operating efficiencies.

## C. Capacity Utilization
   *   **Core Operations Strong:** Sudarshan’s operations and technical functions performing well, with value opportunities identified across legacy systems.  
   *   **Value Capture Accelerating:** Five-theme initiative driving optimization in operations and supply chain; synergies from Roha units already delivering results.  
   *   **"One Sudarshan" Momentum:** Systems and data integration progressing, enabling faster execution and deliberate acceleration of capex-related initiatives.

## D. Manufacturing Footprint
   *   **Strategic Shift to India:** Active transfer of product lines from Germany to India nearing completion, enhancing cost competitiveness.  
   *   **Global Footprint Rationalization:** Consolidation toward lower-cost locations, particularly India, positioned as key driver to achieve **$90–100 Mn EBITDA target**.

---

# 5. Supply Chain & Distribution

## A. Supplier Optimization
   *   **Cost Efficiency Gains:** Supplier landscape optimization and scale-based negotiations have driven improved contract terms via clean-sheet pricing and volume rebates.

## B. Distribution Partners
   *   **Global Channel Restructuring:** Company is actively revising global distribution strategy amid shifting market dynamics, highlighted by the new partnership with **Brenntag** in Australia.

## C. Logistics Shifts
   *   **Tariff-Driven Reallocation:** Product flows redirected to Europe and Mexico to mitigate tariff pressures, with stable logistics patterns elsewhere.

---

# 6. Demand & Inventory Risks

## A. Customer Inventory
   *   **Temporary Demand Setback:** Q2 sales and margins pressured by unexpectedly high customer inventories and slower-than-expected inventory depletion, particularly among global key accounts.
   *   **Margin Distortion:** Gross margin performance negatively impacted by **deinventorization**, which shifted higher operating costs above the gross profit line.
   *   **Working Capital Pressure:** Higher-than-expected working capital due to demand slowdown and elevated customer stockpiles, compounded by inconsistent internal planning systems.
   *   **Outlook Intact:** Despite near-term headwinds from external demand and inventory overhangs, management maintains confidence in its **3- to 4-year growth trajectory**.

---

# 7. Guidance & Outlook

## A. Key Figures
   * Full-Year Guidance (Acquired Group): $25 Mn to $30 Mn
   *   **Current-Year Strategic Guidance:** **€25 Mn to €30 Mn**

## B. Full-Year Forecast
   *   **Downward Revision with Q4 Recovery Hinge:** Full-year outlook for the acquired group lowered due to weak demand, with recovery anticipated in **Q4**; H1 delivered ₹1 Cr.
   *   **Mixed Business Trends:** Despite **subdued Q3 expectations**, certain segments show early signs of recovery, complicating near-term revenue trajectory.
   *   **Divergent Domestic vs. Export Outlook:** Second-half strength expected domestically, while exports to remain soft in **Q3** with rebound forecast from **Q4**.

## C. Long-Term Targets
   *   **Strategic Confidence Intact:** **3- to 4-year guidance unchanged** despite current-year headwinds, underscoring management’s long-term conviction.
   *   **Call for Investor Patience:** Leadership reaffirmed commitment to strategy, emphasizing resilience and future improvement.